Trinitrophenol Reactive T-Cell Hybridomas Recognize Antigens That Require Antigen Processing  by Ma, Jing et al.
Trinitrophenol Reactive T-Cell Hybridomas 
Recognize Antigens That Require Antigen Processing 
Jing Ma,*t Jin-Hong Wang,* Man-Sun Sy,t Ya-Jun Guo,t Conrad Hauser,~: and Michael Bigby* 
'Department of Dermatology and Cutaneous Biology Research Center and the tDepartment of Pathology, Massachusetts General 
Hospital, Boston, Massachusetts, U.S.A. and the :j:Department of Dermatology, Hopital Cantonal Universitaire, Geneva, Switzerland 
Protein antigens must be taken up, processed, and displayed 
on the surface of antigen-presenting cells in association with 
major histocompatibility complex molecules before they can 
be recognized by T cells. Whether recognition of the haptens 
used to study allergic contact hypersensitivity in murine 
models similarly requires processing has not been deter-
mined. We analyzed whether presentation of trinitrophenol 
to trinitrophenol reactive T-cell hybridomas requires antigen 
processing by studying the effects of inhibitors of antigen 
processing and presentation on the ability of a syngeneic 
B-cell tumor (A20) to present trinitrophenol to a series of 
interleukin-2 producing, trinitrophenol specific, major his-
tocompatibility complex class 11 - restricted T-cell hybrid-
omas. 
The ability of trinit~ophenol modified A20 cells to stimu-
late the hybridomas was completely inhibited by monoclo-
nal, anti-trinitrophenol, or anti-Ia antibodies and was signifi-
cantly reduced by paraformaldehyde fixation immediately 
after trinitrophenol modification. Trinitrophenol-modified 
A20 cultured at 37"C for 2 h prior to fixation was signifi-
T he physiology of presentation of soluble protein anti-gens to major histocompatibility complex (MHC) class II - restricted T cells has been well studied. To stimulate MHC class II-restricted T cells to prolifer-ate and secrete lymphokines, antigen-presenting cells 
(APCs) take up soluble protein antigens in pinocytotic vesicles 
where larger proteins are broken down into smaller antigenic pep-
tides by proteolytic enzymes [1]. Only those peptides capable of 
binding to MHC molecules can be immunogenic [2]. Antigenic 
pep tides are then joined by MHC class II a and p chains in the acidic 
compartment of endocytotic vesicles. The MHC class II and anti-
genic peptide complex is then transported to the cell surface where 
the peptide is displayed in association with the MHC class II mole-
cule [3]. The antigenic peptide in association with Ia interacts with 
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cantly more effective at stimulating the hybridomas than 
trinitrophenol-modified A20 fixed immediately. The ability 
of A20 to present trinitrophenol was inhibited by chloro-
quine. Paraformaldehyde fixation and chloroquine treatment 
had similar effects on the ability of trinitrophenol modified 
lymph node dendritic cells to stimulate the trinitrophenol 
specific hybridomas. Paraformaldehyde fixation and chloro-
quine treatment had similar effects on the ability of A20 cells 
to present ovalbumin to ovalbumin-specific hybridomas as 
they had on the ability of trinitrophenol modified A20 cells 
to present trinitrophenol to the trinitrophenol specific hy-
bridomas. One of seven T-cell hybridomas responded to 
trinitrophenol modified ovalbumin but not other trinitro-
phenol modified proteins. These results suggest that, at least 
in part, T cells in the contact hypersensitivity response to 
trinitrophenol recognize antigens that require processing and 
that trinitrophenol modified proteins can be recognized. Key 
words: Antigens/chloroquine/hybridornas/ A20. ] Invest Derrnatol 
103:42-48, 1994 
the T-cell receptor complex of committed T cells that recognize 
both the peptide and a portion of the MHC class II molecule. 
Contact hypersensitivity to simple hap tens in mice is believed to 
be mediated by MHC class II-restricted, CD4-positive T lympho-
cytes [4]. The hapten is therefore recognized in association with the 
MHC class II molecule. Previous studies in guinea pigs demon-
strated that hapten-reactive T cells recognize a complex group of 
processing-dependent and -independent antigens [5 - 8] . However, 
the nature of the nominal antigens (hapten plus self proteins) that 
initiate contact hypersensitivity to the agents used to study contact 
hypersensitivity in the murine system, trinitrochlorobenzene, fluo-
resceine isothiocyanate, dinitrofluorobenzene, and oxazolone, is 
largely unknown. Whether the presentation of contact allergens in 
mice requires antigen processing is similarly unknown. 
We analyzed whether presentation of trinitrophenol (TNP) to 
TNP-reactive T-cell hybridomas requires antigen processing, by 
studying the effects of inhibitors of antigen processing and presen-
tation on the ability of a syngeneic B-cell tumor (A20) to present 
TNP to a panel of interleukin-2 (IL-2)-producing, TNP-specific, 
MHC class II - restricted T-cell hybridomas. Our results indicate 
that, at least in part, T cells in the contact hypersensitivity response 
to TNP recognize antigens that require processing and that TNP-
modified proteins can be recognized. 
MATERIALS AND METHODS 
Production and Characterization of TNP-Specific T-Cell Hybrid-
omas TNP-specific T-cell hybridomas were produced by fusing T lym-
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phocytes from trinitrochlorobenzene (TNCB)-sensitized Balb/c mice with 
the murine thymoma BW5147, using standard techniques [9,10]. The re-
sultant hybridomas were screened for the abi lity to secrete IL-2 when cul-
tured with irradiated, syngeneic, hapten-modified spleen cells. The presence 
of IL-2 in culture supernatants was determined in a bioassay by using an 
IL-2 - dependent cell line, CTLL-20 [11,12] . CTLL-20 cells were originally 
obtained from Dr. S. Gillis, Immunex Corp., Seattle W A, and were kindly 
provided by Dr. Shashi Uniyal , Department of Pathology, Harvard Medical 
School, Boston, MA. Results expressed as counts per minute (cpm) 3H-Thy-
midine incorporation were identical to results expressed as units IL-2/ml 
[11,12]. 
We used monoclonal antibodies (MoAbs) against IL-2 (S4B6) and IL-4 
(liB 11) to determine whether the lymphokine secreted by the hybridomas 
was IL-2 or IL-4 [13-15] . S4B6 was obtained from Dr. Shyr-Te Ju, Boston 
University, Boston and IlBll was from the American Type Culture Col-
lection (ATCC), Rockville, MD. We determined the MHC restriction of 
the hybridomas by using a panel of MoAbs to block IL-2 production by 
hybridomas cultured with TNP-spleen cells or TNP-A20 cells [9]. The 
MoAbs used included 35-5-3S or MKD6 (I_Ad), M5/114 (I_Ad and I_Ed), 
14.4.4S (I-Ed), 34.1.2S (KdDd) , and 10.2.16 (I-Ak). Antibody 14.4.4S is a 
MoAb produced against I_Ek that exhibits broad cross-reactivity, including 
to H_2d. Antibodies were in supernatants from MoAb producing B-cell 
hybridomas obtained from ATCC. 
Antigen Presentation A20 is a B-celilymphoma that expresses I_Ad and 
I_Ed and was obtained from the ATCC [16]. A20 cells were modified at 37" C 
for 10 min with 10 mM trinitrobenzene sulfonic acid (TNBS). Varying 
numbers of TNP-modified A20 (TNP-A20) cells were cultured with 1 X 
105 hybridoma cells in a final volume of200 I.d of incomplete RPMI (with-
out amphotericin B) in 96-well microtiter plates. After 24 h in culture, 
100,u1 of the culture supernatant from groups of cultured cells were re-
moved and assayed for IL-2 activity [9,12]. 
Paraformaldehyde fixation, anti-TNP MoAb, an isotype control MoAb, 
or chloroquine was used to block antigen presentation, abrogating IL-2 
production by the hybridomas. In some experiments, varying amounts of 
anti-TNP MoAb 1B7.11 (ATCC) or an isotype control, anti-diethyltria-
minepentaacetic acid (DTPA) MoAb, 6C3, were added to some wells con-
taining TNP-A20 and hybridoma cells to determine whether anti-TNP 
MoAb would block IL-2 production [17] . In other experiments, TNP-A20 
cells were washed and fixed with varying concentrations of para formal de-
hyde in phosphate-buffered saline (PBS) for 10 min at room temperature 
before or immediately after TNP coupling or at varying times, from 10 min 
to 20 h, after coupling [1] . Fixed and control unfixed TNP-A20 were 
washed four times and then cultured with hybridoma cells as described 
above. 
In chloroquine experiments, A20 cells were incubated for 30 min at 37 °C 
in the presence of 0, 50, 100, 200, or 400,uM chloroquine [18]. The cells 
were washed to remove chloroquine and modified with TNP as described. 
TNP-A20 were washed and then incubated for 2 h in the presence of 0, 50, 
100, 200, or 400 ,uM chloroquine. The cells were washed, fixed with 1 % 
para formaldehyde, washed four times, and used to stimulate TNP-reactive 
hybridomas. 
A20 cells were also used to present chicken egg albumin (OVA) to an I_Ad 
restricted, OVA-specific T-cell hybridoma 0011.10 that was obtained 
from ATCC [19]. A20 cells were incubated in serum-free RPMI containing 
1 gm/ml of OVA at 37"C for 2 h. OVA-pulsed A20 cells were washed and 
varying numbers of OVA-pulsed A20 were cultured with 1 X 105 hybri-
doma cells in a final volume of 200 III of incomplete RPMI (without am-
photericin B) in 96-well micro titer plates. After 24 h in culture, 100,u1 of 
the culture supernatant from groups of cultured cells were removed and 
assayed for IL-2 activity [9,12]. In some experiments, A20 cells were fixed 
with varying concentrations of paraformaldehyde in PBS for 10 min at 
room temperature before being incubated in serum-free RPMI containing 
1 gm/ml of OVA at 37°C for 2 h. The cells were then washed and used to 
stimulate DO 11.1 0 as described above. 
Antigen Presentation by Draining Lymph Node Cells Female 
BALB/c mice were obtained from the Charles River Laboratory, Kingston, 
NY. All mice were used between 6 and 12 weeks of age. Animals in this 
study were maintained in accordance with the guidelines of the Committee 
on Animals of the Harvard Medical School and those prepared by the Com-
mittee on Care and Use of Laboratory Animals of the Institute of Laboratory 
Animal Resources, National Council (DHEW publication No. [NIH] 78-
23, revised 1978). 
Mice were painted on the shaved abdomen, footpads, and ears with 0.5% 
fluorescein isothiocyanate (FITC) in acetone and dibutylphthalate (1 : I, 
v/v). One hundred microliters were applied to the abdomen and 10,u1 to 
each ear and footpad. Twenty-four hours after epicutaneous application of 
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hapten, draining lymph node dendritic cells were isolated by metrizamide 
gradient centrifugation and modified with 10 mM TNBS as described 
[9,20]. Varying numbers ofTNP-modified lymph node dentritic cells were 
cultured with 1 X 105 hybridoma cells in a final volume of200,u1 of inc om-
plete RPMI (without amphotericin B) in 96-well microtiter plates. After 
24 h in culture, 100,u1 of the culture supernatant from groups of cultured 
cells were removed and assayed for IL-2 activity [9]. Paraformaldehyde 
fixation or chloroquine was used to block antigen presentation, abrogating 
IL-2 production by the hybridomas, as described above. 
TNP-Conjugated Proteins and Peptides OVA, bovine albumin and 
insulin, and mouse albumin and fibrinogen wete obtained from Sigma, St. 
Louis, MO. Mouse immunoglobulin was prepared from normal mouse 
serum by ammonium sulfate precipitation and separation using a Protein A 
affinity column. OVA peptide 323-339 was kindly provided by Dr. Julia 
Greenstein, Immulogic, Cambridge, MA or was synthesized by the Harvard 
Microchemistry Facility, Cambridge, MA, from the published amino acid 
sequence [2]. Herpes simplex virus peptide 8-23 (HSV 8-23) was synthesized 
by the Harvard Microchemistry Facility from the published amino acid 
sequence [2]. 
Proteins and peptides were conjugated to TNP by the method of Little and 
Eisen [21] and Good el al [22] . Briefly, proteins were dissolved in PBS, pH 
9.5, at approximately hnM. TNBS was added slowly in the dark and with 
constant stirring. The TNP-modified proteins were stirred for 1 h at room 
temperature. The reaction was terminated by passage through AgI-X8 resin 
(Bio-Rad Laborat?ries, Rich~nond, CAl and the resultant conjugated pro-
tems were then dialyzed agamst PBS, pH 7.40. Protein concentration and 
degree ofTNP coupling were determined by optical density determination 
on a Beckman DU 7500 spectrophotometer. 
Varying concentrations of proteins, peptides, TNP proteins, or TNP pep-
tides were added to 1 X 105 A20 cells and 1 X 105 hybridoma cells in 
duplicate or triplicate in 96-well microtiter plates. After 24 h in culture, 
supernatants were collected and the IL-2 content was determined as de-
scribed. The effects of paraformaldehyde fixation were tested by incubating 
proteins or pep tides with A20 for 2 h or 20 h, washing the cells and incubat-
ing them with paraformaldehyde as described above. Treated cells were 
washed extensively and incubated with hybridoma cells and the IL-2 content 
of supernatants was determined as described. Varying concentrations of 
anti-TNP MoAb were added to some wells in some experiments. 
Statistical Analysis Experiments were performed at least twice and up to 
eight times. Representative results arc shown in Figs 1 - 8 and Tables I and II. 
The statistical significance of differences among means was determined 
using Student t tests. 
RESULTS 
All of the TNP-Specific Hyhridomas were Antigen Specific, 
lad Restricted, and Produced 1L-2 We produced 12 TNP-
specific hybrido~a~ from. our initial fusion of lymph node cells 
from TNCB-sensltlzed mice and BW5147. Seven of these hybrid-
omas have remained stable and antigen responsive, and were further 
characterized and used in subsequent experiments. Two of them 
(2~7.8 and lC6.4.3) were described previously [9]. All of the hy-
bndomas were antigen speCific and none were autoreactive. The 
hybridomas varied greatly in their ability to respond to TNP-modi-
fied spleen cells (TNP-SC). The m.inimum number of TNP-SC 
needed to stimulate the hybridomas varied from as few as 500 to as ' 
many as 2.5 X 105 per well (data not shown). All of the hybridoma5 
responded to SC modified with 10 and 1 rnM TNBS and none 
resp<:nded to 0.1 rnM TNBS (data not shown) [9] . Two of the 
hybndomas (3G7 and 4G 10) were I-Ed restricted' the remaining 
five were I_Ad restricted. All of the hybridomas ~ecreted IL-2 as 
demonstrated by blocking by anti - IL-2 but not by anti - IL-4 MoAb 
(data not shown). 
Anti-TNP and -Ia MoAhs Blocked the Ahility ofTNP-A20 to 
Stimula~e the. Hyhridomas We performed blocking experi-
ments With antl-TNP and -Ia MoAbs to directly demonstrate that 
the hybridomas responded to TNP in association with MHC class II 
molecules. Anti-TNP or -Ia MoAb but not isotype control MoAbs 
blocked the ability ofTNP-A20 to stimulate IL-2 production by the 
hybridomas in a dose-dependent fashion (Fig 1). Similar results 
were obtained with all of the hybridomas (Table I). Anti-TNP and 
-Ia MoAbs also blocked the ability of TNP-SC to stimulate IL-2 
production by all of the hybridomas (data not shown). 
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Figure 1. Anti-TNP and anti-Ia MoAb block the ability of TNP-A20 to 
stimulate the hybridomas. Varying concentrations of MoAb containing su-
pernatant were added to 1 X 105 hybridoma 2C7.8 and 1 X 105 TNP-A20 
cells in triplicate in 96-well plates. After 24 h in culture, 100/11 of superna-
tant were removed and the IL-2 content determined as described. Results arc 
expressed as the means of triplicate samples ± SO. Error bars were omitted 
for SO :5 10% in all figures. 
Previous studies of recognition of TNP in guinea pigs demon-
strated that anti-TNP antibodies blocked the response of TNP-
reactive lymph node T cells to macrophages that were freshly mod-
ified with TNP but did not block the response to syngeneic 
TNP-modified macrophages that were cultured at 37"C for 2 h or 
more [6-8]. We, therefore, cultured TNP-A20 for 2 hat 37"C and 
then determined whether the response of the hybridomas could be 
blocked by anti-Ia or -TNP antibodies. Anti-TNP and -la, but not 
isotype-controlled antibodies, blocked the ability ofTNP-A20 cul-
tured for 2 h to stimulate the hybridomas. Similar results were ob-
tained with all of the hybridomas (Table I) and when TNP-A20 
cells were cultured for 20 h (data not shown). 
Paraformaldehyde-Fixed TNP-A20 Cells were Significantly 
Less Effective at Stimulating the Hybridomas to Produce 
IL-2 Having demonstrated that TNP-specific T-cell hybridomas 
recognized TNP in association with lad, we next sought to deter-
mine whether TNP attached directly to the cell surface of an lad-ex-
pressing APC-required antigen processing. A20 cells were modified 
with TNP, using 10 mM TNBS as described . TNP-A20 that were 
fixed immediately after TNP coupling were significantly less effec-
tive at stimulating the hybridomas than unfixed cells (Fig 2). Simi-
lar results were obtained in three to eight experiments done with 
each hybridoma. 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
To determine whether the effects of paraformaldehyde were 
consistent with the inhibition of antigen processing and presenta-
tion, we allowed TNP-A20 to incubate at 37" C for varying 
amounts of time prior to paraformaldehyde fixation. TNP-A20 
incubated for 2 h before fixation were significantly more effective 
at stimulating the hybridomas to produce IL-2 (Fig 2). In two or 
three experiments done with each hybridoma, TNP-A20 cells al-
lowed to incubate for 2 hat 37"C were consistently more effective 
at stimulating all of the hybridomas than were TNP-A20 cells fixed 
immediately after coupling. 
Varying Concentrations of Paraformaldehyde had Parallel 
Effects on the Ability of A20 Cells to Present OVA to 0011 
and TNP-A20 to Present TNP to TNP-Reactive Hybrid-
omas If presentation ofTNP requires antigen processing, then a 
metabolically inactive cell should not be able to present TNP cou-
pled to its cell surface to a hapten-specific T-cell hybridoma just as a 
metabolically inactive cell cannot present a protein antigen to a 
protein-specific T-cell hybridoma. We, therefore, compared the 
effects of paraformaldehyde on the presentation of TNP to TNP-
specific hybridomas and the presentation of OVA to an OV A-speci-
fic hybridoma. A20 cells were fixed with varying concentrations of 
para formaldehyde prior to TNP coupling or prior to pulsing with 
OVA. The effects of paraformaldehyde fixation on the ability of 
TNP-A20 to stimulate the TNP-reactive hybridomas and the abil-
ity of OVA-pulsed A20 to stimulate DOl1.l0 were compared. 
A20 cells fixed with 1 % paraformaldehyde before TNP coupling 
were consistently unable to stimulate the hybridomas to produce 
IL-2. A20 cells fixed with 1 % paraformaldehyde prior to being 
pulsed with OVA were consistently unable to stimulate DOl1.l0 
to produce IL-2. The effects of varying concentrations of parafor-
maldehyde used to fix A20 prior to TNP coupling paralleled their 
effects on the ability of A20 to present OVA to D011.l0 (Fig 3). 
Chloroquine Blocked the Ability ofTNP-A20 to Stimulate 
the Hybridomas in a Dose-Dependent Fashion Chloroquine 
blocks the ability of APCs to acidify endocytotic vesicles and 
thereby blocks antigen processing [1]. W e tested whether chloro-
quine would block TNP presentation by TNP-A20, abrogating 
IL-2 production by the hybridomas. Chloroquine blocked the abil-
ity of TNP-A20 to stimulate the hybridomas in a dose-dependent 
fashion (Fig 4). In at least two experiments performed with four of 
the hybridomas (2C7.8, IB12.1, 3F2, and 4GI0), 200 11M chloro-
quine inhibited the ability ofTNP-A20 to stimulate the hybridomas 
completely. Exposure to chloroquine after TNP modification also 
blocked the ability of TNP-A20 to stimulate the hybridomas. In 
these experiments, A20 cells were first modified with TNP then 
incubated in medium or 200 JiM chloroquine for 2 h, fixed with 
paraformaldehyde, then used to stimulate hybridoma 2C7.8 (Fig 5) . 
Chloroquine did not affect the viability of cells prior to parafor-
Table I. Effects of MoAbs on Freshly Modified and Cultured TNP-A20 
Experiment l' Experiment 2b 
Hybridoma Control Anti-Ia Anti-TNP Control Anti-Ia Anti-TNP 
2C7.8 49,300 (480) 1090 (50) 1510 (20) 126,740 (1980) 2830 (430) 8240 (410) 
lC6.4 25,640 (350) 7200 (1370) 10,160 (1590) 76,030 (2620) 14,340 (2160) 18,460 (650) 
IB12.1 23,730 (880) 1350 (280) 1670 (10) 93,010 (2600) 2310 (390) 3780 (10) 
3F2 31,080 (3120) NO' 5430 (1070) 18,660 (3270) 2510 (20) 2920 (140) 
lAI 19,290 (350) 1320 (260) 5220 (1840) 61,310 (4910) 24,750 (4490) 7160 (1100) 
3G7 4620 (1500) 2360 (930)NSJ 2140 (30)NS 58,460 (350) 4030 (1000) 6810 (4190) 
4G10 65,620 (2440) NO 13,620 (490) NF' NF NF 
' In experiment I , control or anti-TNP MoAb supernatant in a final concentration of 1: 8 was added to 1 X 105 hybridoma and 1 X 105 freshly modified TNP-A20 cells in 
triplicate in 96-well plates. After 24 h in culture. 100 JlI of supernatant was removed and the IL-2 content determined as described in Fig 10. Results are expressed as the means of 
triplicate samples. The SD appears in parentheses. 
; In experiment 2, TNP-A20 cells were incubated at 37 ' C for 2 h and then washed. 1 X 105 cultured TNP-A20 cells were cultured with control, anti-la, or anti-TNP MoAb 
containing supernatant at a final concentration of 1 : 8 and 1 X 10' hybridoma cells. After 24 h in culture, 100 JlI of supernatant was removed and the lL-2 content determined as 
described in Fig lb. Results are expressed as the means of duplicate samples. The SD appears in parentheses. 
, ND. not done. 
'The differences between control MoAb and anti-Ia or anti· TNP MoAb were all statistically signifieaJlt (p s 0.05) excepr as nored (NS. not significanr). 
, NF, hybridoma not functioning . 
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Figure 2. Paraformaldehyde· fixed TNP-A20 were significantly less effec-
tive at stimulating the hybridomas to produce IL-2. TNP-A20 cells were 
washed and fixed with 1 % para formaldehyde in PBS for 10 min at room 
temperature immediately after coupling or were allowed to incubate for 2 h 
at 37 0 C after TNP coupling and then fixed. Paraformaldehyde-fixed and 
control-unfixed TNP-A20 were washed four times and then cultured with 
1 X 105 hybridoma 2C7.8 cells for 24 h and the IL-2 content of 100 J.lI of 
supernatant determined as described. Results are expressed as the means of 
triplicate samples ± SO. 'Cells fixed immediately were significantly differ-
ent from the other two groups (p :s 0.05). Error bars were ommittcd for 
SD:S 10%. 
maldehyde fixation, as assessed by trypan blue exclusion. To further 
establish that the effects of chloroquine were not due to nonspecific 
toxicity, TNP-A20 cells were cultured at 37"C for 2 h and then 
exposed to varying concentrations of chloroquine for 2t hours at 
37°C. The cells were then fixed with 1% paraformaldehyde and 
their ability to stimulate the hybridomas was determined. Exposure 
to chloroquine did not adversely affect the ability ofTNP-A20 cells 
that had been cultured for 2 h to stimulate the hybridomas (Fig 6). 
Paraformaldehyde Fixation and Chloroquine Treatment In-
hibited the Ability ofTNP-Modified Lymph Node Dendritic 
Cells to Stimulate the TNP-Specific Hybridomas To dem-
onstrate that antigen processing is required for recognition ofTNP 
:iE 
a.. 
() 
80000 
60000 
40000 
20000 
0 .2 0.4 0 .6 0 .8 
2C7.S 
0011.1 0 
1CS.4 
3F4 
1. 0 
Percent Paraformaldehyde 
1. 2 
Figure 3. Varying concentrations of paraformaldehyde had parallel effects 
on the ability of A20 to present OVA to 0011 and TNP-A20 to present 
TNP to TNP-reactive hybridomas. A20 cells that were fixed with va.rying 
concentrations of paraformaldehyde at room temperature for 10 min were 
washed, modified with TNP, and cultured with TNP-specific hybridoma 
2C7.8, lC6.4, or 3F4. After 24 h in culture, the IL-2 content of culture 
supernatants was determined. A20 cells that were identically treated with 
varying concentrations of paraformaldehyde were used to present OVA to 
the OVA-reactive hybridoma, DOll , as described. Results are expressed as 
the means of triplicate samples ± so. Error bars were omitted for so :s 
10%. 
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Figure 4. Chloroquine blocked the abi lity of TNP-A20 to stimulate the 
hybridomas in a dose-dependent fashion. A20 cells were incubated for 30 
min at 37"C in the presence of 0, 50, or 200 J.lM chloroquine. The cells were 
washed and modified with TNP as described. TNP-A20 cells were washed 
and then incubated for 2 h in the presence of, respectively, 0, 50, or 200 J.lM 
chloroquine. The cells were fixed with 1 % paraformaldehyde, washed four 
times, and used to stimulate 1 X 105 TNP-reactive hybridoma 3F2. Results 
are expressed as the means of triplicate samples ± SO. ' Treated groups were 
significantly different from control (p :s 0.05). Error bars were omitted for 
SO:S 10%. 
presented by APCs other than the A20 cell line, we studied the 
effects of para formaldehyde and chloroquine on the ability of 
lymph node dendritic cells to present TNP to the hybridomas. 
Dendritic cells were isolated from regional lymph nodes from 
FITC-painted mice by metrizamide-gradient centrifugation and 
modified with TNP ill Il i/ro, as described. Some TNP-treated den-
dritic cells were fixed with paraformaldehyde immediately or after 
2 h in culture in 37°C, or were treated with chloroquine as de-
scribed. 
TNP-Illodified dendritic cells that were fixed immediately after 
TNP coupling were significantly less effective at stimulating the 
hybridomas than were TNP-modified dendritic cell s incubated for 
2 h prior to fixation (Fig 7). Chloroquine blocked the ability of 
0 .2 0 .4 0 .6 0 . 8 
APCs per Well (x 10 .5) 
1.0 
2 hrs at 37' then fixed 
2 hrs in chloroquine then fixed 
fixed Immediately 
1.2 
Figure 5. Exposure to chloroquine after TNP modification also blocked 
the ability of TNP-A20 to stimulate the hybridomas. A20 cells were first 
modified with TNP, washed, and then incubated in medium or 200 J.lM 
chloroquine for 2 h. The cells were then fixed with 1 % paraformaIdehyde, 
washed, and used to stimulate 1 X 105 TNP-reactive hybridoma 2C7.8. 
Cells fixed immediately after TNP modification were used as negative con-
trols. Results are expressed as units of IL-2/ml ± SO. 'Cells fixed immedi-
ately or exposed to chloroquine immediately after coupling differed signifi-
cantly from cells allowed to incubated in medium for 2 h (p :s 0.05). Error 
bars were omitted for SO :s 10%. 
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Figure 6. Exposure to chloroquine did not affect the ability TNP-A20 cells 
that had been cultured for 2 h to stimulate the hybridomas. TNP-A20 were 
cultured for 2 hat 37"C and were then exposed to varying concentrations of 
chloroquine for 2t hours at 37'C. The cells were then fixed with 1% 
paraformaldehyde and their ability to stimulate the hybridoma 2C7.8 was 
determined. Error bars were omitted for SO :5 10%. 
TNP-modified lymph node dendritic cells to stimulate the hybrid-
omas in a dose-dependent fashion (Fig 8). 
One of the TNP-Reactive Hybridomas Responded to a TNP-
Modified Protein To explore the possibility that the contact 
hypersensitivity response to hapten may occur by recognition of 
TNP-modified proteins, we tested the ability of the hybridomas to 
respond to a series of TNP-modified proteins . The TNP proteins 
used included proteins that are in highest concentration in mouse 
plasma and interstitial fluid (albumin, fibrinogen, and immuno-
globulin), a protein known to be immunogenic in Balb/c mice 
(ovalbumin), and two randomly chosen proteins (bovine insulin and 
albumin) [2,3J. 
None of the hybridomas responded to TNP conjugated to mouse 
albumin, fibrinogen, or immunoglobulin, or to TNP conjugated to 
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Figure 7. Paraformaldehyde fixation inhibited the ability ofTNP-modi-
fied lymph node dendritic cells to stimulate the TNP-specific hybridomas. 
Lymph node dendritic cells that were isolated from FITC-painted mice by 
metrizamide gradient centrifugation were modified with 10 mM TNBS as 
described. TNP-modified lymph node dendritic cells were washed and fixed 
with 1 % paraformaldehyde in PBS for 10 min at room temperature immedi-
ately after coupling or were allowed to incubate for 2 h at 37"C after TNP 
coupling and then fixed. The paraformaldehyde-fixed cells were washed 
four times and then cultured with 1 X 105 hybridoma 2C7.8 cells for 24 h 
and the IL-2 content of 100 III of the supernatant was determined as de-
scribed. Results are expressed as the means of triplicate samples ± SO. 'The 
differences were statistically significant (p :5 0.05). Error bars were omitted 
for SO :5 10%. 
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Figure 8. Chloroquine blocked the ability ofTNP-modified lymph node 
dendritic cells to stimulate the hybridomas in a dose-dependent fashion. 
Lymph node dendritic cells that were isolated from FITC-painted mice by 
metrizamide gradient centrifugation were incubated for 30 min at 37'C in 
the presence of 0, 50, or 200 IlM chloroquine. The cells were washed and 
modified with TNP as described. TNP-modified lymph node dendritic cells 
were washed and then incubated for 2 h in the presence, respectively, of 0, 
50, or 200 IlM chloroquine. The cells were fixed with 1 % paraformalde-
hyde, washed four times, and used to stimulate 1 X 105 TNP-reactive hybri-
doma 2C7 .8. Results are expressed as the means of triplicate samples ± SO. 
'Treated groups were significantly different than control (p :5 0.05). Error 
bars were omitted for SO :5 10%. 
bovine insulin or albumin. One of the hybridomas, 2C7.8, re-
sponded strongly and consistently to TNP-OVA (Table II). One 
other hybridoma, 1 C6.4.3, responded weakly to TNP-OV A. 
OVA peptide 323-339 is known to bind to I_Ad and to be the 
antigenic peptide in the response of OVA-specific hybridomas and 
T-cell clones [2]. We tested the ability ofTNP-OVA peptide 323-
339 and a control TNP peptide to stimulate 2C7.8 to produce IL-2. 
Neither TNP-OVA peptide 323-339 nor the control TNP-HSV 
peptide 8-23 stimulated 2C7.8 to produce IL-2 (data not shown). 
The Response to TNP-OV A was Class IT Restricted, TNP 
Specific, and Could Be Blocked by OVA We used the anti-
TNP and -Ia MoAbs to demonstrate directly that the response of 
2C7.8 to TNP-OV A was specific for TNP and class II restricted. 
Table IT. Characterization of the Response of 2C7.8 
to TNP-OVA 
Experiment 1" 
Experiment 2b 
Experiment 3' 
Inhibitor 
anti-Ia MoAb 
Control MoAb 
anti-TNP MoAb 
Control MoAb 
Ovalbumin 
Mouse albumin 
Cpm (SD) 
Without 
Inhibitor 
65,870 (2670) 
76,290 (3400) 
40,780 (2040) 
40,710 (4410) 
32,460 (3760) 
33,440 (2220) 
With 
Inhibitor 
11,720 (550) 
71,330 (5490) 
20,700 (7860) 
41,150 (8140) 
16,590 (6770) 
36,160 (6540) 
'In experiment 1, A20 cells were cultured with TNP·OVA at 37"C for 20 h, 
washed, and thell cultured with control or anti-la Moab containing supernatant at a 
final concentranon of 1:8 and 1 X 10' 2C7.8 cells. After 24 h in culture, 100 JlI of 
supernatant was removed and the IL-2 content determined. Results arc expressed as the 
means of tnphcate samples. The SD appears in parentheses. 
b In experiment 2, A20 cells were cultured with TNP-OVA at 37"C for 20 h, 
washed, and then cultured with control or anti-TNP MoAb containing supernatant at a 
final concentratton of 1 : 8 and 1 X 10' 2C7.8 cells. After 24 h in culture, 100/11 of 
supernatant w~s removed and the IL-2 content determined. Results arc expressed as the 
means of tnpheate samples. The SD appears in parentheses. 
.' In exp~riment 3, 2C7.8 and A20 cells were cultured with TNP·OV A (250 Jlg/ml) 
With or Without OVA (2 mg/ml) or mouse albumin (2 mg/ml). After 24 h in culture, 
100,lll of supernatant was removed and the IL-2 content determined. Results arc ex· 
pressed as the means of triplicate samples. The SD appears in parentheses. 
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Anti-TNP MoAb but not an isotype control MoAb inhibited the 
response of 2C7.8 to TNP OVA. Anti-Ia MoAb but not a control 
MoAb inhibited the response of 2C7.8 to TNP-OVA (Table II). 
Thus, like the response to TNP-A20, the response of 2C7.8 to 
TNP-OV A is specific for TNP and is Ia restricted. 
We used OVA to block presentation ofTNP-OVA to 2C7.8 to 
demonstrate that a haptenated protein antigen is presented to T cells 
by the same pathway a.s protein antigens. C?? A, but not a control 
protein (mouse albuml11), blocked the abilIty of A20 to present 
TNP-OVA to 2C7.8. (Table II). 
DISCUSSION 
We produced a series ofTNP-reactive T-cell hybridomas and uti-
lized them to study the antigen processing and presentation require-
ments for MHC class-II-restricted TNP recognition. Utilizing hy-
bridomas to study antigen processing and presentation requirements 
has many obvious advantages over using the itl vivo ear-swelling 
model, polyclonal hapten-reactive T cells, or T-cell clones [23]. 
Hybridomas do not require second signals to induce IL-2 produc-
tion, as do T-cell clones, and thus are an ideal tool to study antigen 
processing in the absence of second signals [24]. Hybridomas give 
resul ts consistent with the results obtained with T-cell clones, with 
normal T cells from immunized mice, and with results obtained 
with itl vivo sensitization [9,23,25,26]. 
Because the response of the hybridomas to TNP-A20 was 
blocked by anti-MHC class II MoAbs or by the anti-TNP MoAb, 
TNP must be intimately associated with the MHC class II molecule 
to be recognized. The nominal antigens responsible for the devel-
opment of contact allergy to TNCB may, however, be quite nu-
meroUS and diverse. In broad categories, they would include TNP 
directly bound to MHC class II molecules, TNP bound to pep tides 
already occupying the antigen-binding groove of the MHC class II 
molecule, intracellular or extracellular TNP-modified proteins, or 
TNP-coupled cell-surface proteins. TNP directly coupled to the 
MHC class II molecule or to peptides occupying the antigen-bind-
ing groove would be immediately immunogenic and would not 
require additional processing, whereas haptenated intracellular, ex-
tracellular, or cell-surface proteins would require processing and 
association with the MHC class II molecule to become immuno-
genic and recognizable by T cells [1-3]. 
A20 cells fixed with paraformaldehyde prior to TNP coupling 
were unable to stimulate the hybridomas to produce IL-2. There 
was also a significant reduction in the ability ofTNP-A20 to stimu-
late the hybridomas when they were fixed immediately after TNBS 
coupling. Allowing TNP-A20 to incubate at 37°C for 2 h before 
fixation uniformly increased their ability to stimulate the hybrid-
omas. These data imply that a processing step is required to present 
TNP to TNP-reactive T-cell hybridomas. Therefore, TNP directly 
bound to the MHC class II molecule or to peptides already occupy-
ing the antigen-binding groove are unlikely to be solely responsible 
for stimulating the hybridomas to produce IL-2. 
Para formaldehyde treatment may produce its effects by inhibit-
ing the ability of APCs to provide second signals or by destroying 
the tertiary structure of the antigen. These possibilities are not en-
tirely satisfactory explanations for the observed effects of para for-
mal de hyde treatment for several reasons. First, hybridomas do not 
require second signals to produce lymphokines in response to anti-
gen [24]. Second, TNP-modified APCs that are allowed time to 
process TNP-modified antigens (e.g., TNP-A20 or TNP-modified 
lymph node dendritic cells allowed to incubate at 3TC for 2 h) 
were more capable of stimulating the hybridomas even after para-
formaldehyde fixation than were cells fixed immediately after cou-
pling. Third, paraformaldehyde fixation diminishes but does not 
abolish the ability of protein-pulsed A20 cells to fresent pep tides to 
class-II - restricted, peptide-reactive hybridomas 27]. Finally, para-
formaldehyde fixation diminishes but does not abolish the ability of 
A20 cells to be recognized by an I-Ad-reactive hybridoma, 19.52 
(data not shown) [28]. 
We compared the effects of using varying concentrations of para-
formaldehyde between 0.2% and 1 % on the ability of A20 to 
present OVA to an OVA-specific hybridoma (DOll) (a process 
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known to require antigen processing) and the ability of TNP-A20 
to present TNP to TNP-specific hybridomas. The varying concen-
trations of paraformaldehyde had parallel effects on the ability of 
A20 to present OVA to DOll and the ability of TNP-A20 to 
present TNP to TNP-specific hybridomas (Fig 3). These results 
imply that fixed, metabolically inactive A20 cells were unable to 
present TNP to TNP-specific T-cell hybridomas, just as metaboli-
cally inactive A20 cells were unable to present OVA to an OVA-
specific T-cell hybridoma. 
These results differ from those of Thomas, who found that mac-
rophages fixed with low concentrations of gluteraldehyde and then 
modified with TNP retained the ability to stimulate TNP-reactive 
lymph node T cells much more than comparably fixed macrophages 
pulsed with purified protein derivative (PPD) were able to stimulate 
PPD-reactive T cells [29]. A plausible explanation for these differ-
ences in results may be that guinea pig macrophages contain self 
peptides in the class II binding site that can be haptenated and 
recognized by T cells without further processing, whereas murine 
lad molecules on A20 cells do not. Another explanation, that TNP is 
directly coupled to class II molecules, is less likely because Thomas 
produced biochemical evidence that TNP is not directly coupled to 
guinea pig class II molecules isolated from TNP-modified macro-
phages [30]. 
Previous studies in guinea pigs demonstrated that TNP-modified 
macrophages fixed immediately after coupling were capable of 
stimulating TNP-reactive T cells from syngeneic guinea pigs. The 
response was class II restricted and blocked by anti-TNP antibodies. 
TNP-modified macrophages that were cultured for 2-24 h at 
37°C before fixation were also capable of stimulating TNP-reactive 
T cells. However, in contrast to our results, the response could not 
be blocked by anti-TNP antibodies. The differences in results may 
be explained by differences in the position or orientation of hapten-
modified residues (most likely lysines) of hapten-modified peptides 
that are being recognized. In our system, hapten-modified lysines 
may be facing upward in the antigen-binding site of the lad mole-
cules. Martin et al. have demonstrated that recognition of TNP-
lysine-containing pep tides presented by murine MHC class I mol-
ecules (Kb) can be blocked by anti-TNP MoAb and concluded the 
TNP moiety is facing upward in the antigen-binding groove [31]. 
The lack of blocking by anti-TNP antibodies by Thomas and She-
vach may be explained if the TNP-Iysine is facing downward (i.e., 
into the class II molecule) or is in a position in the groove inaccessi-
ble to anti-TNP antibodies [8]. 
We used chloroquine, a more selective inhibitor of antigen pro-
cessing, to try to confirm that antigen processing is required for 
TNP recognition. Chloroquine inhibits acidification of endocyto-
tic vesicles and has been demonstrated to inhibit processing and 
presentation of protein antigens [1] . Chloroquine inhibited the abil-
ity of TNP-A20 to stimulate the hybridomas in a dose-dependent 
fashion without affecting .cell ,:iability by try pan blue exclusion (Fig 
4). Exposure to chloroqul11e did not affect the ability ofTNP-A20 
cells that had been cultured for 2 h to stimulate the hybridomas. 
Thus the effects of chloroquine were not due simply to nonspecific 
toxicity. The inhibitory effects of chloroquine were not due to 
interference with TNP coupling to the surface. Chloroquine inhib-
ited the ability of A20 cells to present TNP to the hybridomas even 
when cells were not pre incubated in media containing chloroquine 
(Fig 5). Furthermore, coupling the cells to TNP in the presence of 
200.uM chloroquine produced nearly identical results (data not 
shown). Thus the data with chloroquine are consistent with pro-
cessing being required for optimal recognition of TNP. 
Paraformaldehyde fixation and chloroquine treatment inhibited 
the ability ofTNP-modified lymph node dendritic cells to stimulate 
the TNP-specific hybridomas (Figs 7 and 8). Lymph node dendritic 
cells that migrate from the skin to regional lymph nodes are be-
lieved to be responsible for initiating the contact hypersensitivity 
responses. These experiments demonstrate that antigen processing 
is similarly required for TNP to be presented by lymph node den-
dritic cells. 
The possibility that antigen processing was required for TNP 
recognition led us to study whether TNP-modified proteins could 
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be recognized by the hybridomas. TNP-OV A was the only protein 
that A20 cells were able to present to the hybridomas and only one 
of the hybridomas, 2C7.8, was able to recognize it. We conclude 
from these experiments that some T cells generated in response to 
TNCB are capable of recognizing processed TNP proteins. Recog-
nition of three different specificities, hapten, a peptide, and a MHC 
class II molecule, are required for the activation of this T-cell hybri-
doma. Evidence confirming this hypothesis was reported by 
Nalefski and Rao, who demonstrated that an azobenzenarsenate-
specific, I-Ad-restricted T-cell hybridoma recognized an azoben-
zenearsonate-conjugated peptide bound to I_Ad. Interestingly, the 
azobenzenearsonate-conjugated peptide was derived from azoben-
zenarsenate-OVA [32]. TNP-OVA was also recognized by T cells 
responsive to TNP-modified macro phages in guinea pigs [8]. Simi-
lar recognition of TNP peptides has been demonstrated for MHC 
class I (Kb)-restricted CTL clones [31 ,33]. These clones, like our 
hybridomas, were generated in response to TNP-modified cells. 
Martin et al. identified an immunogenic, Kb-restricted TNP peptide 
motif that consisted of MHC class I binding residues at positions 5 
and 8 and TNP-modified lysines at positions 4 or 7 [31]. Whether 
endogenous proteins modified with TNP can similarly stimulate 
TNP-reactive T cells remains to be determined. 
Our results do not entirely exclude the possibility that TNP cou-
pled directly to the MHC class II molecule or to pep tides already 
occupying the antigen binding site of the MHC class II molecule 
can stimulate the hybridomas. Paraformaldehyde fixation immedi-
ately after coupling did not completely abolish the ability ofTNP-
A20 to stimulate the hybridomas. I_Ad does contain a lysine at resi-
due 75 in the third hypervariable region of the ex chain, in a position 
that potentially could be recognized by T cells [34]. Experiments to 
determine whether hapten coupled directly to lad molecules or to 
peptides already occupying the antigen-binding site can stimulate 
the hybridomas are in progress. 
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